PNC Financial Services Group
KRTX

PNC Financial Services Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

PNC Financial Services Group’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-202
Closed -$63.9K – 4849
2023
Q4 		$63.9K Buy
202
+85
+73% +$16.5K ﹤0.01% 2845
2023
Q3 		$19.8K Sell
117
-35
-23% -$6.58K ﹤0.01% 3436
2023
Q2 		$33K Buy
152
+71
+88% +$15.2K ﹤0.01% 3284
2023
Q1 		$14.7K Sell
81
-849
-91% -$162K ﹤0.01% 3634
2022
Q4 		$183K Buy
930
+796
+594% +$171K ﹤0.01% 2187
2022
Q3 		$29K Buy
134
+67
+100% +$13.6K ﹤0.01% 3271
2022
Q2 		$9K Sell
67
-21
-24% -$2.41K ﹤0.01% 3858
2022
Q1 		$11K Buy
88
+13
+17% +$1.46K ﹤0.01% 3809
2021
Q4 		$10K Buy
75
+9
+14% +$1.16K ﹤0.01% 3802
2021
Q3 		$8K Buy
66
+46
+230% +$5.31K ﹤0.01% 3822
2021
Q2 		$2K Buy
20
+13
+186% +$1.52K ﹤0.01% 4068
2021
Q1 		$1K Buy
+7
New +$793 ﹤0.01% 4066
2020
Q2 		– Sell
-9
Closed -$1K – 4083
2020
Q1 		$1K Buy
+9
New +$770 ﹤0.01% 3841

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

PNC Financial Services Group's KRTX Position: Q1 2024 in Review

PNC Financial Services Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 202 shares — an estimated $63.9K sold.

PNC Financial Services Group first reported a position in KRTX in Q1 2020 and held it in 13 quarters. The position peaked at $183K in Q4 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • PNC Financial Services Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 202 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $63.9K.
  • PNC Financial Services Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 13 quarters.
  • PNC Financial Services Group's Karuna Therapeutics, Inc. Common Stock position peaked at $183K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on PNC Financial Services Group's 13F filing for Q1 2024, filed 10 May 2024.